Long‐term safety and durability of multiple anti‐TNFα switches in pediatric inflammatorybowel disease: A SIGENP multicenter study

Key Points

• The study aims to evaluate the long-term safety and effectiveness of multiple anti-TNFα switches in children with inflammatory bowel disease.
• Multicenter study design
• Analysis focused on relapse rates, adverse events, and treatment durability
• Pediatric population with inflammatory bowel disease was assessed
• No significant increase in relapse rates observed
• No notable rise in adverse events reported
• Durability of treatment remained stable despite multiple switches